These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36638770)

  • 21. Late onset multiple sclerosis.
    Arias M; Dapena D; Arias-Rivas S; Costa E; López A; Prieto JM; Corredera E
    Neurologia; 2011 Jun; 26(5):291-6. PubMed ID: 21163234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pediatric multiple sclerosis: is it different from the adult form?].
    Araqi-Houssaini A; Dany F; Sekkat Z; Camara NA; Hazim A; Midafi N; Elotmani H; El Moutawakil B; Rafai MA; Slassi I
    Rev Neurol (Paris); 2014; 170(8-9):531-5. PubMed ID: 25174885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late onset multiple sclerosis: concerns in aging patients.
    Lotti CBC; Oliveira ASB; Bichuetti DB; Castro I; Oliveira EML
    Arq Neuropsiquiatr; 2017 Jul; 75(7):451-456. PubMed ID: 28746432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.
    Butler Pagnotti R; Hua LH; Miller JB
    Mult Scler; 2022 May; 28(6):933-941. PubMed ID: 34410177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late onset multiple sclerosis - multiparametric MRI characteristics.
    Jasek Ł; Śmigielski J; Siger M
    Neurol Neurochir Pol; 2020; 54(3):265-271. PubMed ID: 32368786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Late onset multiple sclerosis: Is it really late onset?
    Roohani P; Emiru T; Carpenter A; Luzzio C; Freeman J; Scarberry S; Beaver G; Davidson L; Parry G
    Mult Scler Relat Disord; 2014 Jul; 3(4):444-9. PubMed ID: 25877055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Epidemiological Aspects of Late Onset Multiple Sclerosis in East-Azerbaijan, Iran; A Population-Based Study.
    Nasiri E; Naseri A; Abbasgholizadeh P; Fahidi A; Talebi M
    Arch Iran Med; 2022 Nov; 25(11):725-729. PubMed ID: 37543896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis in the elderly: a retrospective cohort study.
    Zinganell A; Göbel G; Berek K; Hofer B; Asenbaum-Nan S; Barang M; Böck K; Bsteh C; Bsteh G; Eger S; Eggers C; Fertl E; Joldic D; Khalil M; Langenscheidt D; Komposch M; Kornek B; Kraus J; Krendl R; Rauschka H; Sellner J; Auer M; Hegen H; Pauli FD; Deisenhammer F
    J Neurol; 2024 Feb; 271(2):674-687. PubMed ID: 37855871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case-control study.
    Abbasi Kasbi N; Ghane Ezabadi S; Kohandel K; Khodaie F; Sahraian AH; Nikkhah Bahrami S; Mohammadi M; Almasi-Hashiani A; Eskandarieh S; Sahraian MA
    BMC Neurol; 2024 Sep; 24(1):327. PubMed ID: 39243006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple Sclerosis Progression and Relapse Activity in Children.
    Iaffaldano P; Portaccio E; Lucisano G; Simone M; Manni A; Guerra T; Paolicelli D; Betti M; De Meo E; Pastò L; Razzolini L; Rocca MA; Ferrè L; Brescia Morra V; Patti F; Zaffaroni M; Gasperini C; De Luca G; Ferraro D; Granella F; Pozzilli C; Romano S; Gallo P; Bergamaschi R; Coniglio MG; Lus G; Vianello M; Banfi P; Lugaresi A; Totaro R; Spitaleri D; Cocco E; Di Palma F; Maimone D; Valentino P; Torri Clerici V; Protti A; Maniscalco GT; Salemi G; Pesci I; Aguglia U; Lepore V; Filippi M; Trojano M; Amato MP;
    JAMA Neurol; 2024 Jan; 81(1):50-58. PubMed ID: 38010712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
    D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
    Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Course and prognosis in early-onset MS: comparison with adult-onset forms.
    Simone IL; Carrara D; Tortorella C; Liguori M; Lepore V; Pellegrini F; Bellacosa A; Ceccarelli A; Pavone I; Livrea P
    Neurology; 2002 Dec; 59(12):1922-8. PubMed ID: 12499484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modelling the natural history of primary progressive multiple sclerosis.
    Harding KE; Wardle M; Moore P; Tomassini V; Pickersgill T; Ben-Shlomo Y; Robertson NP
    J Neurol Neurosurg Psychiatry; 2015 Jan; 86(1):13-9. PubMed ID: 24828900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of early versus late disability accumulation in primary progressive MS.
    Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older-Onset Multiple Sclerosis.
    Knowles S; Middleton R; Cooze B; Farkas I; Leung YY; Allen K; Winslade M; Owen DRJ; Magliozzi R; Reynolds R; Neal JW; Pearson O; Nicholas R; Pickrell WO; Howell OW;
    Ann Neurol; 2024 Mar; 95(3):471-486. PubMed ID: 38061895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple sclerosis in older adults: the clinical profile and impact of interferon Beta treatment.
    Shirani A; Zhao Y; Petkau J; Gustafson P; Karim ME; Evans C; Kingwell E; van der Kop ML; Oger J; Tremlett H
    Biomed Res Int; 2015; 2015():451912. PubMed ID: 25922836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    He A; Merkel B; Brown JWL; Zhovits Ryerson L; Kister I; Malpas CB; Sharmin S; Horakova D; Kubala Havrdova E; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T;
    Lancet Neurol; 2020 Apr; 19(4):307-316. PubMed ID: 32199096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and long term prognosis in early onset multiple sclerosis.
    Deryck O; Ketelaer P; Dubois B
    J Neurol; 2006 Jun; 253(6):720-3. PubMed ID: 16502213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.